NCT05103683
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05103683
Title First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Acronym TRIO049
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TORL Biotherapeutics, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Providence Medical Foundation RECRUITING Fullerton California 92835 United States Details
UCLA - JCCC Clinical Research Unit RECRUITING Los Angeles California 90095 United States Details
University of Kentucky Medical Center RECRUITING Lexington Kentucky 40536 United States Details
University of Minnesota RECRUITING Minneapolis Minnesota 55455 United States Details
Mayo Clinic in Rochester RECRUITING Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
Sarah Cannon Research Institute Texas Oncology RECRUITING Tyler Texas 75702 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
St. Vincent's Hospital, The Catholic University of Korea RECRUITING Suwon Gyeonggi-do 16247 South Korea Details
Seoul National University Hospital RECRUITING Seoul 03080 South Korea Details
Severance Hospital RECRUITING Seoul 03723 South Korea Details
Asan Medical Center RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field